When steroid particles reach the tumour microenvironment, they may bind to SRC-1 gene receptor (Fig. 3) Typically, steroid particles are expected to inhibit the regulation of the SRC-1 gene, which would lead to a reduction in its expression in tumor microenvironment. The gene discussed is NCOA1; the disease is neoplasm.